Cancer patients are highly vulnerable to SARS-CoV-2 infections due to frequent contacts
with the healthcare system, immunocompromised state from cancer or its therapies …

Lung cancer, considered one of the most common causes of cancer deaths worldwide, is a
complex disease with its own challenges. The coronavirus disease 2019 (COVID-19) …

Multidisciplinary team is beneficial to select an appropriate treatment plan for a patient with
lung cancer, where the collected cognitive evaluation information may be uncertain and …

Background The coronavirus disease 2019 (COVID-19) pandemic poses a great challenge
to the treatment of lung cancer patients. Materials and methods The PubMed, Embase, and …

Abstract Treatment management of cancer patients in the radiation oncology departments
during the current COVID-19 pandemic is challenging. A systematic review of published …

COVID-19 pandemic generated concerns about the healthcare of patients with cancer, not
simply because of the formidable impact of COVID-19 patients in the public healthcare …

Objective In this review, we evaluate the role of liquid biopsy in managing lung cancer
patients during the still ongoing coronavirus disease 2019 (COVID-19) healthcare …

Simple Summary The consequences of the first lockdown and the accompanying strict
health restrictions on lung cancer patients during the first COVID-19 wave are a public …

Abstract Coronavirus disease 2019 (COVID-19) continues as a global pandemic. Patients
with lung cancer infected with COVID-19 may develop severe disease or die. Treating such …

Introduction Lung cancer is treated using systemic therapy, radiation therapy (RT), and
surgery. This study evaluates how utilization of these modalities and cancer stage at initial …